Mahon Paul Ainsider trades
In SEC Form 4 filings, Mahon Paul A is listed as EVP & GENERAL COUNSEL of UNITED THERAPEUTICS Corp (UTHR). In the last 90 days, Mahon Paul A sold $21.68M of UNITED THERAPEUTICS Corp (UTHR) on the open market and bought none. All 43 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| UTHRUNITED THERAPEUTICS Corp | EVP & GENERAL COUNSEL | 55 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | M | 8,300 | $146.03 | $1,212,049 | 53,472 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | S | 268 | $541.64 | Sale −$145,160 | 53,204 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | S | 1,924 | $542.49 | Sale −$1,043,753 | 51,280 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | S | 1,983 | $543.56 | Sale −$1,077,871 | 49,297 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | S | 791 | $544.85 | Sale −$430,975 | 48,506 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | S | 2,615 | $545.69 | Sale −$1,426,972 | 45,891 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | S | 719 | $546.56 | Sale −$392,977 | 45,172 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 15 | Oct 16 | M · derivative | 8,300 | $146.03 | $1,212,049 | 30,940 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | M | 8,300 | $146.03 | $1,212,049 | 53,472 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 880 | $558.30 | Sale −$491,308 | 52,592 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 1,480 | $560.19 | Sale −$829,083 | 51,112 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 780 | $561.87 | Sale −$438,259 | 50,332 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 1,480 | $563.09 | Sale −$833,374 | 48,852 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 400 | $566.41 | Sale −$226,562 | 48,452 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 720 | $567.76 | Sale −$408,788 | 47,732 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 739 | $569.15 | Sale −$420,600 | 46,993 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 838 | $570.90 | Sale −$478,411 | 46,155 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 823 | $572.25 | Sale −$470,961 | 45,332 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | S | 160 | $573.15 | Sale −$91,704 | 45,172 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Oct 1 | Oct 1 | M · derivative | 8,300 | $146.03 | $1,212,049 | 39,240 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | M | 8,300 | $146.03 | $1,212,049 | 53,472 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 1,579 | $495.97 | Sale −$783,132 | 51,893 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 2,873 | $496.58 | Sale −$1,426,662 | 49,020 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 1,400 | $497.54 | Sale −$696,561 | 47,620 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 843 | $498.74 | Sale −$420,435 | 46,777 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 1,160 | $499.75 | Sale −$579,712 | 45,617 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 125 | $500.80 | Sale −$62,600 | 45,492 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | S | 320 | $501.58 | Sale −$160,506 | 45,172 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 17 | Sep 18 | M · derivative | 8,300 | $146.03 | $1,212,049 | 47,540 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | M | 8,300 | $146.03 | $1,212,049 | 53,472 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 1,545 | $478.93 | Sale −$739,954 | 51,927 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 936 | $479.66 | Sale −$448,959 | 50,991 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 2,360 | $480.86 | Sale −$1,134,833 | 48,631 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 1,048 | $481.92 | Sale −$505,049 | 47,583 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 160 | $482.66 | Sale −$77,226 | 47,423 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 200 | $483.85 | Sale −$96,770 | 47,223 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 954 | $485.12 | Sale −$462,807 | 46,269 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 598 | $486.47 | Sale −$290,908 | 45,671 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 169 | $487.36 | Sale −$82,364 | 45,502 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 10 | $488.32 | Sale −$4,883 | 45,492 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | S | 320 | $490.89 | Sale −$157,083 | 45,172 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Sep 3 | Sep 3 | M · derivative | 8,300 | $146.03 | $1,212,049 | 55,840 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | M | 2,690 | $146.03 | $392,821 | 47,862 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | M | 5,610 | $146.03 | $819,228 | 53,472 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 2,690 | $524.15 | Sale −$1,409,964 | 50,782 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 502 | $520.03 | Sale −$261,057 | 50,280 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 1,819 | $521.04 | Sale −$947,773 | 48,461 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 787 | $522.00 | Sale −$410,817 | 47,674 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 850 | $522.78 | Sale −$444,366 | 46,824 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 192 | $523.69 | Sale −$100,548 | 46,632 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 940 | $525.25 | Sale −$493,735 | 45,692 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 400 | $526.39 | Sale −$210,554 | 45,292 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | S | 120 | $527.21 | Sale −$63,265 | 45,172 | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | M · derivative | 2,690 | $146.03 | $392,821 | not reported | Yes | Form 4 |
| UTHRUNITED THERAPEUTICS Corp | Aug 20 | Aug 21 | M · derivative | 5,610 | $146.03 | $819,228 | 64,140 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.